Table 1.

Baseline demographic characteristics and vaccination rates of participating practices (practices, N=11; patients ages 11–17, N=9,473)

						Vaccination rates
Site	N	11–13 years, %	Females, %	Non-white race, %	Commercial insurance, %	HPV initiation, %	HPV completion, %	Meningococcal, %	Tdap, %	Influenza, %
A	158	38.6	60.8	3.2	47.5	48.8	38.0	83.5	83.6	17.0
B	160	27.5	49.4	6.3	63.8	44.6	26.6	80.9	81.9	21.8
C	165	28.5	43.0	10.3	64.2	64.8	29.2	75.5	75.8	23.6
D	242	31.4	50.1	10.7	59.9	65.8	34.8	78.6	79.0	17.7
E	258	38.0	53.9	45.4	15.9	51.8	24.4	70.1	69.4	46.5
F	422	35.1	55.5	88.4	32.0	41.7	32.2	63.9	60.7	22.7
G	1,120	40.4	50.1	1.2	82.2	35.6	20.0	76.8	79.3	40.2
H	1,368	42.0	48.7	30.5	78.4	38.1	27.2	69.0	70.9	51.6
I	1,400	44.1	48.7	11.6	89.9	54.2	33.1	84.5	84.7	46.4
J	2,066	48.6	49.4	88.1	25.5	47.4	30.9	79.9	80.6	39.2
K	2,114	41.7	48.3	2.0	68.7	35.1	16.1	74.3	74.7	40.9
Total	9,473	42.3	49.6	31.7	61.6	52.0	30.6	79.1	79.5	40.5

Note: HPV=human papillomavirus vaccine; Tdap=tetanus, diphtheria and pertussis vaccine